| Reckitt Benckiser (Switzerland) AG - Gaviscon Liquid Mint, Suspension zum Einnehmen im Beutel | | 62887 | | 02 | | Gaviscon Liquid Mint | | Suspension zum Einnehmen im Beutel | | A02AX | | Antacids, Other Combinations | | 05.06.2013 | | |
| | Composition | | natrii alginas 500 mg, natrii hydrogenocarbonas 267 mg, calcii carbonas 160 mg, carbomerum 974P, natrii hydroxidum ad pH, aqua purificata, aromatica (Minze), saccharinum natricum, propylis parahydroxybenzoas 6 mg, E 218 40 mg, ad suspensionem pro 10 ml corresp. natrium 142.6 mg. | | Packungsbestandteile | | Suspension zum Einnehmen in Sachets | | | | | | Active Agent | Dose |
|---|
| Calcium Carbonate | 160 mg | | Sodium Alginate | 500 mg | | Sodium Hydrogen Carbonate | 267 mg |
| | | | Inactive agents | | additional_information |
|---|
| Aromatica | | | | E 218 | | conserv. | | Propylis Parahydroxybenzoas | | conserv. | | Saccharinum Natricum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 12 Sachet(s) | | | D | | Yes | | 005 | 24 Sachet(s) | | | D | | No |
|
|
